U.S. CDC Advisers Recommend RSV Vaccine For Adults Aged 75 Years Of Age And Above; Recommend RSV Vaccine For Adults 60–74 Years Of Age Who Are At Increased Risk Of Severe RSV Disease
Portfolio Pulse from Benzinga Newsdesk
U.S. CDC advisers have recommended the RSV vaccine for adults aged 75 years and above, and for adults aged 60-74 who are at increased risk of severe RSV disease.
June 26, 2024 | 7:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CDC's recommendation for RSV vaccine for older adults could boost demand for Moderna's RSV vaccine, potentially increasing revenue.
The CDC's recommendation is likely to increase the demand for RSV vaccines among older adults, benefiting companies like Moderna that produce these vaccines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
CDC's recommendation for RSV vaccine for older adults could boost demand for Pfizer's RSV vaccine, potentially increasing revenue.
The CDC's recommendation is likely to increase the demand for RSV vaccines among older adults, benefiting companies like Pfizer that produce these vaccines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80